Capital Advisors Inc. OK Raises Stake in Medtronic PLC $MDT

Capital Advisors Inc. OK raised its holdings in Medtronic PLC (NYSE:MDT) by 24.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 590,228 shares of the medical technology company’s stock after purchasing an additional 117,590 shares during the quarter. Capital Advisors Inc. OK’s holdings in Medtronic were worth $56,213,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. AXQ Capital LP grew its stake in shares of Medtronic by 25.6% in the 2nd quarter. AXQ Capital LP now owns 9,890 shares of the medical technology company’s stock valued at $862,000 after purchasing an additional 2,013 shares during the last quarter. Legacy Advisory Services LLC acquired a new stake in shares of Medtronic during the first quarter worth $541,000. GC Wealth Management RIA LLC grew its position in Medtronic by 20.6% in the 2nd quarter. GC Wealth Management RIA LLC now owns 33,569 shares of the medical technology company’s stock valued at $2,926,000 after buying an additional 5,734 shares during the last quarter. Merit Financial Group LLC increased its stake in Medtronic by 37.5% in the 2nd quarter. Merit Financial Group LLC now owns 57,035 shares of the medical technology company’s stock valued at $4,972,000 after buying an additional 15,561 shares during the period. Finally, Verdence Capital Advisors LLC raised its position in Medtronic by 22.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 29,396 shares of the medical technology company’s stock worth $2,562,000 after buying an additional 5,296 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MDT has been the topic of several analyst reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Medtronic in a report on Monday, December 29th. Cowen reaffirmed a “buy” rating on shares of Medtronic in a report on Friday, November 14th. Wall Street Zen downgraded Medtronic from a “buy” rating to a “hold” rating in a research note on Saturday. Wells Fargo & Company raised their price target on Medtronic from $100.00 to $114.00 and gave the company an “overweight” rating in a report on Wednesday, November 19th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $110.00 price objective on shares of Medtronic in a report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Medtronic currently has an average rating of “Moderate Buy” and an average price target of $109.94.

Medtronic Price Performance

Shares of NYSE:MDT opened at $96.03 on Friday. The firm has a market capitalization of $123.11 billion, a price-to-earnings ratio of 25.88, a price-to-earnings-growth ratio of 2.53 and a beta of 0.71. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. The business’s 50 day simple moving average is $97.65 and its 200-day simple moving average is $94.07. Medtronic PLC has a 12 month low of $79.55 and a 12 month high of $106.33.

Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.05. The company had revenue of $8.96 billion for the quarter, compared to the consensus estimate of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.Medtronic’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.26 earnings per share. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, equities analysts forecast that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.

Medtronic Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s dividend payout ratio is presently 76.55%.

Medtronic Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).